Neuropace, Inc. Common Stock
$14.10
-$0.15 (-1.05%)
$14.04Day Range$14.57
Key Statistics
Market Cap
$483.97M
Shares Outstanding
34.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 22, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$14.28
Day High
$14.57
Day Low
$14.04
Volume
116.1K
VWAP
$14.18
Prev Close
$14.25
Transactions
--
Acc. Volume
--
About Neuropace, Inc. Common Stock
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841220 employees455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043(650) 237-2700IPO Apr 22, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001528287
- Composite FIGI
- BBG001KWZD52
- Share Class FIGI
- BBG001V0SVB1
- Ticker Root
- NPCE
- SIC Code
- 3841
About Neuropace, Inc. Common Stock (NPCE) Stock
Neuropace, Inc. Common Stock (NPCE) closed the 2026-09-16 session at $14.10, down 1.05% versus the previous close (-0.15). The stock opened at $14.28 and traded between $14.04 and $14.57 during that session. Session trading volume was 116K shares. The volume-weighted average price (VWAP) is $14.18.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Neuropace, Inc. Common Stock has a market capitalization of $484.0 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. NPCE is listed on the XNAS exchange. The company employs approximately 220 people. Neuropace, Inc. Common Stock is headquartered in MOUNTAIN VIEW, CA. The recorded listing date is 2021-04-22.
On this page you can find market NPCE stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.